Brain-Induced Neurotrophic Factor Levels in Patients Undergoing Coronary Artery Bypass Surgery

Overview

In patients undergoing coronary artery bypass surgery, the relationship between neurocognitive changes seen in the early period and brain-induced neurotrophic factor serum levels will be investigated.

Full Title of Study: “The Relationship Between Neurocognitive Changes and Brain-Induced Neurotrophic Factor Levels in Patients Undergoing Coronary Artery Bypass Surgery”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: August 15, 2020

Detailed Description

Although postoperative cognitive dysfunction (POKD) is the most common neurological complication in patients undergoing coronary artery bypass grafting (CABG) surgery, its pathophysiology is still not fully understood. However, the quality of this dysfunction has not been properly measured. In addition to clinical tests, biomarkers are often used to detect the presence of POKD. In this study, it was aimed to evaluate the relationship between intraoperative and postoperative brain-derived neurotrophic factor serum levels and POKD in patients undergoing CABG surgery. This prospective observational study is planned to include 30 adult patients aged 40-90 years. Patients with stroke history, neurodegenerative disease, seizure history, alcohol use, general anxiety, hearing deficit, unilateral carotid artery stenosis greater than 70%, and carotid artery bilateral stenosis greater than 50% will be excluded from the study. This study aimed to determine perioperative changes in serum brain-derived neurotrophic factor levels in patients undergoing CABG surgery.

Interventions

  • Diagnostic Test: Patients with cognitive dysfunction
    • Mini Mental Test Those with a score below 21 points

Clinical Trial Outcome Measures

Primary Measures

  • Postoperative cognitive dysfunction
    • Time Frame: 4 days
    • Relationship between serum brain-derived neurotrophic factor level and cognitive dysfunction

Participating in This Clinical Trial

Inclusion Criteria

  • At Least Primary School Graduates, – Not Using Drugs That May Affect Cognitive Functions, – No Alcohol Substance Use, – Without Psychiatric And Neurological Diseases Exclusion Criteria:

  • Uneducated Patients, – Drug Users Who May Affect Cognitive Functions (Antipsychotic, Antidepressant), – Have Alcohol And Substance Use Disorders, – Those With A History Of Central Nervous System Disease That May Cause Cognitive Dysfunction (Such As Stroke, Neurodegenerative Disease, Seizure, General Anxiety), – Hearing Deficit, – Patients With Unilateral Carotid Artery Stenosis Greater Than 70% And Bilateral Stenosis Greater than 50% Carotid Artery

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Bozok University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ökkeş Hakan Miniksar, Asist.Prof. – Bozok University
  • Overall Official(s)
    • Yozgat Bozok University Research Hospital, Study Director, Yozgat

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.